These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Quantification of the infectivity of Cryptosporidium parvum by monitoring the oocyst discharge from SCID mice. Hikosaka K; Satoh M; Koyama Y; Nakai Y Vet Parasitol; 2005 Nov; 134(1-2):173-6. PubMed ID: 16076530 [TBL] [Abstract][Full Text] [Related]
13. Inability of interferon-gamma and aminoguanidine to alter Cryptosporidium parvum infection in mice with severe combined immunodeficiency. Kuhls TL; Mosier DA; Abrams VL; Crawford DL; Greenfield RA J Parasitol; 1994 Jun; 80(3):480-5. PubMed ID: 7515109 [TBL] [Abstract][Full Text] [Related]
14. Molecular targets for detection and immunotherapy in Cryptosporidium parvum. Boulter-Bitzer JI; Lee H; Trevors JT Biotechnol Adv; 2007; 25(1):13-44. PubMed ID: 17055210 [TBL] [Abstract][Full Text] [Related]
15. Protection from Cryptosporidium parvum infection by gammadelta T cells in mice that lack alphabeta T cells. Eichelberger MC; Suresh P; Rehg JE Comp Med; 2000 Jun; 50(3):270-6. PubMed ID: 10894490 [TBL] [Abstract][Full Text] [Related]
16. Cryptosporidium parvum infection after abrogation of natural killer cell activity in normal and severe combined immunodeficiency mice. Rohlman VC; Kuhls TL; Mosier DA; Crawford DL; Greenfield RA J Parasitol; 1993 Apr; 79(2):295-7. PubMed ID: 8459345 [TBL] [Abstract][Full Text] [Related]